Virus Plus is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Deseret Biologicals, Inc.. The primary component is Influenza A Virus A/singapore/gp1908/2015 Ivr-180a (h1n1) Antigen (propiolactone Inactivated); Influenza A Virus A/hong Kong/4801/2014 X-263b (h3n2) Antigen (propiolactone Inactivated); Influenza B Virus B/brisbane/60/2008 Antigen (propiolactone Inactivated); Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen; Human Adenovirus B Serotype 7 Strain 55142 Antigen; Human Herpesvirus 1; Human Herpesvirus 2; Human Herpesvirus 5; Human Herpesvirus 4; Hepatitis B Virus; Norwalk Virus.
| Product ID | 43742-1117_64eac1e9-a72e-47a4-ac6b-fb2d7ad9e768 |
| NDC | 43742-1117 |
| Product Type | Human Otc Drug |
| Proprietary Name | Virus Plus |
| Generic Name | Influenzinum (2017-2018), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-12-14 |
| Marketing End Date | 2023-08-22 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
| Labeler Name | Deseret Biologicals, Inc. |
| Substance Name | INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (PROPIOLACTONE INACTIVATED); HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 4; HEPATITIS B VIRUS; NORWALK VIRUS |
| Active Ingredient Strength | 12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL |
| NDC Exclude Flag | N |
| Marketing Start Date | 2017-12-14 |
| Marketing End Date | 2023-08-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2017-12-14 |
| Marketing End Date | 2023-08-22 |
| Ingredient | Strength |
|---|---|
| INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED) | 12 [hp_X]/mL |
| SPL SET ID: | 85de8efd-7a53-451a-9465-6beb976e3f6e |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 43742-0397 | Virus Plus | Influenzinum, Adenoviren Nosode, Herpes Simplex 1, Herpes Simplex 2, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode |
| 43742-0539 | Virus Plus | Influenzinum, Adenoviren Nosode, Herpes Simplex 1, Herpes Simplex 2, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode |
| 43742-0559 | Virus Plus | Influenzinum, Adenoviren Nosode, Herpes Simplex 1, Herpes Simplex 2, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus |
| 43742-0736 | Virus Plus | Influenzinum (2015-2016), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode |
| 43742-0807 | Virus Plus | Influenzinum (2015-2016), Adenoviren Nosode, Herpes Simplex 1, Herpes Simplex 2, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode |
| 43742-0960 | Virus Plus | Influenzinum (2016-2017), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode |
| 43742-1117 | Virus Plus | Influenzinum (2017-2018), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode |
| 43742-1396 | Virus Plus | Influenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode |